{
    "organizations": [],
    "uuid": "555415b5d570d5a3ba2fb6d2160e18dccf91aba3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medigene-receives-approvals-for-fi/brief-medigene-receives-approvals-for-first-clinical-trial-with-mdg1011-idUSFWN1QA188",
    "ord_in_thread": 0,
    "title": "BRIEF-Medigene Receives Approvals For First Clinical Trial With MDG1011",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - Medigene AG:\n* SAYS RECEIVES APPROVALS FOR ITS FIRST CLINICAL TRIAL WITH TCR THERAPY MDG1011\n* SAYS PAUL-EHRLICH-INSTITUTE AND THE RELEVANT ETHICS COMMITTEE HAVE APPROVED STUDY DESIGN OF PHASE I/II CLINICAL TRIAL WITH MDG1011​\n* ‍SAYS EXPECTS TO START TRIAL WITHIN COMING WEEKS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-21T14:39:00.000+02:00",
    "crawled": "2018-02-22T18:22:54.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "medigene",
        "ag",
        "say",
        "receives",
        "approval",
        "first",
        "clinical",
        "trial",
        "tcr",
        "therapy",
        "mdg1011",
        "say",
        "relevant",
        "ethic",
        "committee",
        "approved",
        "study",
        "design",
        "phase",
        "clinical",
        "trial",
        "expects",
        "start",
        "trial",
        "within",
        "coming",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}